Parabilis Medicines' IPO has lived up to the hype—securing $670 million for the largest listing in t...
Cancer-focused Parabilis’ upsized $670M IPO breaks new record for biotechs
Parabilis Medicines' IPO has lived up to the hype—securing $670 million for the largest listing in the sector's history. The cancer biotech, formerly known...
Author: Fierce Biotech
Read Original Article